Título : Effect of continuous positive airway pressure in very elderly with moderate-to-severe obstructive sleep apnea pooled results from two multicenter randomized controlled trials |
Autor : Martínez-García, M. A. Oscullo, G. Ponce, S. Pastor, E. Orosa, B. Catalán, P. Martínez, A. Hernandez Blasco, Luis M.  Muriel, A. Chiner, Eusebi  Vigil, L. Carmona, C. Mayos, M. Garcia-Ortega, A. Gomez-Olivas, J. D. |
Editor : Elsevier |
Departamento: Departamentos de la UMH::Medicina Clínica |
Fecha de publicación: 2022-01 |
URI : https://hdl.handle.net/11000/34878 |
Resumen :
Study objective: There is very limited information about the effect of continuous positive airway pressure (CPAP) in the very elderly. Here we aimed to analysed the effect of CPAP on a clinical cohort of patients with obstructive sleep apnea (OSA) ≥80 years old.
Methods: Post-hoc pooled analysis of two open-label, multicenter clinical trials aimed to determine the effect of CPAP in a consecutive clinical cohort of elderly (≥70 years old) with moderate-to-severe OSA (apnea-hipopnea index ≥15 events/hour) randomized to receive CPAP or no CPAP for three months. Those consecutive patients ≥80 years old were included in the study. The primary endpoint was the change in Epworth Sleepiness scale (ESS). Secondary outcomes included sleep-related symptoms, quality of life, neurocognitive and mood status as well as office blood pressure measurements.
Results: From the initial 369 randomized individuals with ≥70 years, 97 (26.3%) with ≥80 years old were included (47 in the CPAP group and 50 in the no-CPAP group). The mean (SD) age was 81.5 (2.4) years. Average use of CPAP was 4.3 (2.6) hours/night (53% with good adherence) Patients in the CPAP group significantly improved snoring and witnessed apneas as well as AHI (from 41.9 to 4.9 events/hour). However no clinical improvements were seen in ESS (-1.2 points, 95%CI, 0.2 to -2.6), any domain of QSQ, any neurocognitive test, OSA-related symptoms, depression/anxiety or blood pressure levels.
Conclusions: The present study does not support the use of CPAP in very elderly patients with moderate-to-severe OSA.
|
Palabras clave/Materias: OSA CPAP Very elderly Obstructive sleep apnea Neurocognitive Quality of life |
Tipo de documento : info:eu-repo/semantics/article |
Derechos de acceso: info:eu-repo/semantics/closedAccess Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
DOI : 10.1016/j.sleep.2021.11.009 |
Aparece en las colecciones: Artículos Medicina Clínica
|